Publicacións en colaboración con investigadores/as de Imperial College Healthcare NHS Trust (2)

2020

  1. Real-world effectiveness and safety of glecaprevir/pibrentasvir for the treatment of patients with chronic HCV infection: A meta-analysis

    Journal of Hepatology, Vol. 72, Núm. 6, pp. 1112-1121

2016

  1. Randomized controlled trial of the NS5A inhibitor daclatasvir plus pegylated interferon and ribavirin for HCV genotype-4 (COMMAND-4)

    Antiviral Therapy, Vol. 21, Núm. 3, pp. 195-205